Consistent with recent years, 2026 has proved to be a busy year for children and teens’ privacy legislation. This post recaps notable developments and trends thus far in 2026. Our mid-year and end-of-year recaps for 2025 can be found here and here.
July 2026
Brazil’s 2026 Election and its Impact to Businesses and Investors
Executive Summary
On October 4, 2026, more than 150 million Brazilian voters will cast their votes in first-round elections for a new president and all state governors, and will also elect all members of the House of Deputies, two-thirds of the Federal Senate, and state-level representatives. Brazil is the second-largest democracy in the Western Hemisphere,…
FCC Restricts Imports of New Foreign-Produced Power Inverters and Advanced Robotic Devices with Additions to its Covered List
On July 28, 2026, the FCC added foreign-produced power inverters and advanced robotic devices to its Covered List, following determinations by an executive branch interagency body that they pose “unacceptable risks” to the national security of the United States. The new additions continue a string of decisions placing entire categories of foreign-produced devices on…
Non-Compete Roundup Summer 2026 – New Limitations on Restrictive Covenants
A number of states have recently acted to introduce new limitations on employers’ use of restrictive covenants, continuing a trend of tightening up on employers’ options for protecting their confidential information, especially in the use of non-competition agreements. On July 1, 2026, Tennessee and Virginia implemented expansive restrictions on non-competes for employees earning less than…
The $10 Million TINA Threshold Is Now in Effect: What Contractors and Subcontractors Need to Know
By Michael Pierce & Nooree Lee
Last December, we previewed the significant cost accounting and pricing data disclosure changes contained in the Fiscal Year 2026 National Defense Authorization Act (“NDAA”), including Section 1804(c)’s increase to the threshold governing the Truthful Cost or Pricing Data Statute (formerly the Truth in Negotiations Act, and still commonly called “TINA”). That change is no longer…
Defense Department Publishes Guidance Page Concerning Restrictions on Defense Contractors Retaining Outside Consultants
Over the last month, we have issued multiple client alerts outlining developments related to the Chinese military company covered lobbyist prohibition enacted by Section 851 of the National Defense Authorization Act (“NDAA”) for Fiscal Year (“FY”) 2025, codified at 10 U.S.C. § 4663. This is a follow-up to those prior alerts to address…
Third Circuit Raises the Bar for Proving Causation Through Statistical Evidence in RICO Pharmaceutical Fraud Class Actions
The Third Circuit recently vacated and remanded a district court’s decision granting class certification for a class of third-party payors (“TPPs”) pursuing Racketeer Influenced and Corrupt Organizations Act (“RICO”) claims against GlaxoSmithKline LLC (“GSK”). See In re Avandia Mktg., Sales Pracs. & Prod. Liab. Litig., 2026 WL 2093904 (3d Cir. July 21, 2026). The TPPs’…
No Misfire, No Case: Eighth Circuit Decertifies Gun-Defect Class Action Over Standing
Owning a product that might malfunction isn’t enough for Article III standing—the defect must actually manifest. That’s the message from Glasscock v. Sig Sauer, Inc., __ F.4th __, 2026 WL 2054200 (8th Cir. July 16, 2026), where the Eighth Circuit vacated class certification and dismissed the case after the named plaintiff admitted his firearm had…
Department of Energy Selects 278 Genesis Mission Projects
As we covered in our previous blog post, the Department of Energy (“DOE”) has launched the “Genesis Mission” to apply AI technology to a wide variety of scientific and technological challenges.
Last week, DOE announced it had selected 278 Genesis Mission projects for potential awards. The selected projects span nuclear energy, quantum computing, advanced…
What does the GKV-BStabG Reform Change for Pharma Pricing & Reimbursement in Germany? And the Reforms Are Not Over: What to Expect From the New German Minister of Health and the Pharma Dialogue?
Tomorrow, on 30 July 2026, the “GKV-Beitragssatzstabilisierungsgesetz” (GKV-BStabG) will enter into force, marking the culmination of a fast-paced and politically contentious legislative process. The reform, which has attracted significant attention, introduces a broad package of cost-containment measures across the statutory health insurance (GKV) system. Several of these specifically target pharmaceutical spending and reimbursement and are…